BIGUANID-VERBINDUNGEN

European patent · EP3131877 · In force

Register entry

Publication number
EP3131877
Application number
EP15780117
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Apr 17, 2015
Published
Feb 22, 2017
Granted
Jul 19, 2023
Protection ends at the latest
Apr 16, 2035
Next annual fee due
Apr 30, 2027
IPC classes
C07C 279/26 (2006.01)
C07D 333/10 (2006.01)
C07C 279/04 (2006.01)
Priority
KR 20140046290 17.04.2014
KR 20140080133 27.06.2014
KR 20140133135 02.10.2014
PCT application
PCT/KR2015/003884 17.04.2015
PCT publication
WO2015/160220 22.10.2015
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 1, 2026

    Change

    Published in Swissreg on 01.05.2026

  2. May 1, 2025

    Change

    Published in Swissreg on 01.05.2025

  3. May 29, 2024

    Change

    Published in Swissreg on 29.05.2024

  4. May 1, 2024

    Change

    Published in Swissreg on 01.05.2024

  5. Jul 19, 2023

    Granted

    Published in Swissreg on 19.07.2023

Parties

Holder

Immunomet Therapeutics Inc.

JLABS at Texas Medical Center 2450 Holcombe Blvd,, Houston, TX 77021, US

Inventor

HEO, Hye Jin

Daejeon 305-509, KR

KIM, Hong Woo

Daejeon 305-790, KR

KOOK, Ji Ae

Daejeon 306-710, KR

LEE, Young Woo

Daejeon 305-509, KR

KIM, Mi Jeong

Seoul 138-820, KR

LEE, Hong Bum

Daejeon 305-728, KR

YOO, Sang Hee

Daejeon 305-509, KR

LEE, Ji Sun

Daejeon 305-741, KR

CHO, Woong

Seongnam-si Gyeonggi-do 463-400, KR

KIM, Sung Wuk

Seongnam-si Gyeonggi-do 463-802, KR

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.